RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis
Authors:
- Verena SiglVSVerena Sigl
- Josef M. PenningerJPJosef M. Penninger
- 1 May 2011
- journal article
- review article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 22 (5) , 188-194
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signallingNature, 2011
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancerNature, 2010
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate CancerNew England Journal of Medicine, 2009
- The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouseDevelopmental Biology, 2009
- Human Osteoclast-Poor Osteopetrosis with Hypogammaglobulinemia due to TNFRSF11A (RANK) MutationsThe American Journal of Human Genetics, 2008
- Regulation of cancer cell migration and bone metastasis by RANKLNature, 2006
- Generation of a functional mammary gland from a single stem cellNature, 2006
- Purification and unique properties of mammary epithelial stem cellsNature, 2006
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002